EMD-24696

Single-particle
3.3 Å
EMD-24696
3D View Gallery
Deposition: 16/08/2021
Map released: 24/08/2022
Last modified: 04/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-24696

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7ru4 summary report (pdf.gz) Map-7ru4 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement)

EMD-24696

Single-particle
3.3 Å
EMD-24696
3D View Gallery
Deposition: 16/08/2021
Map released: 24/08/2022
Last modified: 04/06/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: CC6.33 IgG in complex with SARS-2-CoV-6P-Mut7 S protein
Fitted models: 7ru4

Deposition Authors: Ozorowski G, Turner HL, Ward AB
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.
Zhao F , Keating C, Ozorowski G, Shaabani N, Francino-Urdaniz IM, Barman S, Limbo O , Burns A, Zhou P , Ricciardi MJ, Woehl J , Tran Q, Turner HL, Peng L, Huang D, Nemazee D, Andrabi R, Sok D, Teijaro JR, Whitehead TA, Ward AB, Burton DR, Jardine JG
(2022) iScience , 25 , 104914 - 104914
PUBMED: 35971553
DOI: doi:10.1016/j.isci.2022.104914
ISSN: 2589-0042